Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Filings indexed 1,397 across all filing types
Latest filing 2025-10-15 Proxy Solicitation & In…
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2025-10-15 English
SC TO-C Filing
Regulatory Filings
2025-10-10 English
PRIMARY DOCUMENT
Director's Dealing
2025-10-06 English
PRIMARY DOCUMENT
Director's Dealing
2025-10-06 English
OTHER PRELIMINARY PROXY STATEMENTS
Regulatory Filings
2025-10-03 English
SC TO-C Filing
Regulatory Filings
2025-10-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.